End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
42.1 CNY | -1.45% | -3.95% | -6.92% |
Jun. 05 | Hengrui Pharma Units Get China Nod for Clinical Trial of Tumor Drug | MT |
May. 30 | Hengrui Pharmaceuticals Gets Nod to Trial Vitiligo Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.92% | 37.48B | |
+48.18% | 780B | |
+41.76% | 627B | |
+19.97% | 334B | |
+7.04% | 296B | |
+17.60% | 244B | |
-0.41% | 217B | |
+11.54% | 214B | |
+4.21% | 161B | |
-3.37% | 159B |
- Stock Market
- Equities
- 600276 Stock
- News Jiangsu Hengrui Medicine Co., Ltd.
- Hengrui Grants Rights to Bain Capital-Backed Company for Anti-Diabetes Treatment